כמות מזומנים למניה Cadrenal Therapeutics Inc (CVKD)

סמל תאגידי ולוגו של Cadrenal Therapeutics (CVKD)

The absence of proprietary manufacturing plants and a strategic focus on a digital back-office have triggered a surge in cash per share for Cadrenal Therapeutics (CVKD). This growth confirms the status of Cadrenal Therapeutics (CVKD) as a developer of safe alternatives to legacy anticoagulants. Recognition from nephrologists for reducing stroke risks strengthens brand confidence. The value of 0.75 indicates the level of this metric, capturing the issuer's current liquidity.

CVKD Cadrenal Therapeutics Inc: יתרות מזומנים למניה בטווח 28.04.2023 - 20.11.2026

פילוחים אנליטיים של חברת Cadrenal Therapeutics

- מחיר נוכחי ושווי מניות חזוי:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח כללי של החברה:Cadrenal Therapeutics - CVKD
מוצר עיקרי של cadrenal.com

Cadrenal Therapeutics (CVKD) is investing in eco-friendly chemical disposal and logistics optimization to comply with ESG standards. This metric reflects the volume of liquid assets per common share. Analyzing cash per share over the period allows for an assessment of financial stability and default risk. The stability of this metric confirms the business's ability to fund research and development without external borrowing. Current price action determines the market maturity of the biopharmaceutical company.